Eltrombopag Drugs Market Strength Driven by Asia-Pacific and Latin...

toegevoegd een audio Health

2025-07-11 10:09:55 -

Eltrombopag Drugs Market Strength Driven by Asia-Pacific and Latin America Expansion

The global Eltrombopag drugs market is projected to reach around US$ 5.1 billion by 2034, rising from US$ 2.4 billion in 2024. This growth, at a CAGR of 7.8% from 2025 to 2034, is mainly driven by rising cases of blood-related disorders. Eltrombopag is widely used to treat chronic immune thrombocytopenia (ITP) and severe aplastic anemia (SAA), both rare but serious conditions where the body...

0 Reacties 0 aandelen 35 Views